Literature DB >> 34758912

Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Immune Checkpoint Inhibitor Therapy in Prostate Cancer.

Ivan de Kouchkovsky1, Hsin-Yu Chen2, Michael A Ohliger2, Zhen J Wang2, Robert A Bok2, Jeremy W Gordon2, Peder E Z Larson2, Mary Frost2, Kimberly Okamoto2, Matthew R Cooperberg3, John Kurhanewicz2, Daniel B Vigneron2, Rahul Aggarwal4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34758912      PMCID： PMC9275093          DOI： 10.1016/j.eururo.2021.10.015

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   24.267


× No keyword cloud information.
  5 in total

1.  Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer.

Authors:  Rahul Aggarwal; Xiao Wei; Won Kim; Eric J Small; Charles J Ryan; Peter Carroll; Matthew Cooperberg; Michael J Evans; Thomas Hope
Journal:  Eur Urol Oncol       Date:  2018-05-15

2.  Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer.

Authors:  Rahul Aggarwal; Daniel B Vigneron; John Kurhanewicz
Journal:  Eur Urol       Date:  2017-07-29       Impact factor: 20.096

3.  Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate.

Authors:  Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron; Peder E Z Larson; Andrea L Harzstark; Marcus Ferrone; Mark van Criekinge; Jose W Chang; Robert Bok; Ilwoo Park; Galen Reed; Lucas Carvajal; Eric J Small; Pamela Munster; Vivian K Weinberg; Jan Henrik Ardenkjaer-Larsen; Albert P Chen; Ralph E Hurd; Liv-Ingrid Odegardstuen; Fraser J Robb; James Tropp; Jonathan A Murray
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

Review 4.  Rationale for Modernising Imaging in Advanced Prostate Cancer.

Authors:  Anwar R Padhani; Frederic E Lecouvet; Nina Tunariu; Dow-Mu Koh; Frederik De Keyzer; David J Collins; Evis Sala; Stefano Fanti; H Alberto Vargas; Giuseppe Petralia; Heinz Peter Schlemmer; Bertrand Tombal; Johann de Bono
Journal:  Eur Urol Focus       Date:  2016-07-15

5.  Hyperpolarized 13C-pyruvate MRI detects real-time metabolic flux in prostate cancer metastases to bone and liver: a clinical feasibility study.

Authors:  Hsin-Yu Chen; Rahul Aggarwal; Robert A Bok; Michael A Ohliger; Zi Zhu; Philip Lee; Jeremy W Gordon; Mark van Criekinge; Lucas Carvajal; James B Slater; Peder E Z Larson; Eric J Small; John Kurhanewicz; Daniel B Vigneron
Journal:  Prostate Cancer Prostatic Dis       Date:  2019-11-04       Impact factor: 5.554
  5 in total
  2 in total

1.  Metabolic response to immunotherapy in prostate cancer.

Authors:  Tim Thomas
Journal:  Nat Rev Urol       Date:  2022-01       Impact factor: 14.432

Review 2.  MRI techniques for immunotherapy monitoring.

Authors:  Doreen Lau; Pippa G Corrie; Ferdia A Gallagher
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.